Enhanced growth of tumors in SPARC null mice is associated with changes in the ECM

Rolf A Brekken1, Pauli Puolakkainen, David C Graves

  • 1Department of Vascular Biology, The Hope Heart Institute, Seattle, Washington 98104-2046, USA.

Insights

Secreted acidic rich protein (SPARC) is crucial for regulating the tumor microenvironment. Mice lacking SPARC showed faster tumor growth, indicating SPARC

Area of Science:

  • Biochemistry
  • Oncology
  • Extracellular Matrix Biology

Background:

  • Secreted acidic rich protein (SPARC) is a glycoprotein involved in cell-matrix interactions, morphogenesis, and differentiation.
  • SPARC exhibits de-adhesion and anti-proliferative functions in vitro and is expressed in remodeling tissues, including tumors.
  • The role of endogenous SPARC in tumor progression remains largely unknown.

Purpose of the Study:

  • To investigate the function of endogenous SPARC in tumor growth and progression using a mouse model.
  • To determine the impact of SPARC deficiency on the tumor microenvironment, including extracellular matrix (ECM) organization and immune cell infiltration.

Main Methods:

  • Implantation of tumors into SPARC-null and wild-type mice.
  • Analysis of ECM component production and organization within tumors.
  • Assessment of macrophage infiltration and angiogenic growth factor levels.
  • Evaluation of tumor cell proliferation and apoptosis in vivo and in vitro.

Main Results:

  • Tumors implanted in SPARC-null mice exhibited significantly accelerated growth compared to wild-type controls.
  • SPARC deficiency led to altered ECM production and organization and reduced macrophage infiltration in tumors.
  • No significant changes in angiogenic growth factor levels were observed, but total vascular area differed.
  • SPARC inhibited tumor cell growth in vitro but showed no demonstrable effect on proliferation or apoptosis in vivo.

Conclusions:

  • Host-derived SPARC plays a critical role in organizing the tumor microenvironment, particularly the ECM, in response to tumor implantation.
  • The ECM, regulated by SPARC, is a key factor influencing tumor growth.
  • These findings highlight SPARC's importance in modulating the tumor microenvironment and suggest potential therapeutic strategies targeting ECM remodeling.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...